Bacteriocin BaCf3

General Information


DRACP ID  DRACP04376

Peptide Name   Bacteriocin BaCf3

Sequence  GNHDCCMGQLPKCMLGPGQGAATCQGK

Sequence Length  27

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C107H177N35O35S6

Absent amino acids  EFIRSVWY

Common amino acids  G

Mass  317014

Pl  7.93

Basic residues  3

Acidic residues  1

Hydrophobic residues  4

Net charge  2

Boman Index  -2139

Hydrophobicity  -36.3

Aliphatic Index  36.3

Half Life 
  Mammalian: 1.4 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  250

Absorbance 280nm  9.62

Polar residues  12

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  3D Structure Elucidation and Appraisal of Mode of Action of a Bacteriocin BaCf3 with Anticancer Potential Produced by Marine Bacillus amyloliquefaciens BTSS3

Doi Not available

Year  2022

Literature 2

Pubmed ID 30863715

Title  BaCf3: highly thermostable bacteriocin from Bacillus amyloliquefaciens BTSS3 antagonistic on food-borne pathogens

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19213

DRACP is developed by Dr.Zheng's team.